CLOMID 50 Para-Pharma ā Clomiphene Citrate for Men
Doctors first prescribed clomiphene citrate to women as a selective estrogen receptor modulator (SERM) to trigger ovulation. Today, many men use it in bodybuilding and recovery to stimulate natural testosterone production after anabolic steroid cycles.
š Key Benefits
- Boosts testosterone: Clomiphene stimulates LH and FSH release, which activates the testes.
- Effective PCT support: Athletes include it in Post Cycle Therapy to restore natural hormones.
- Controls estrogen rebound: It lowers the risk of gynecomastia and mood issues.
- Precise dosing: Each tablet delivers 50 mg for consistent results.
š Pharmacology
Clomiphene citrate belongs to the class of SERMs. It blocks estrogen receptors in the hypothalamus. As a result, the pituitary gland increases the release of gonadotropins (LH and FSH). These hormones stimulate the testes, and testosterone levels rise naturally in men.
āļø Usage & Dosing
Men take CLOMID 50 Para-Pharma orally. During PCT, they usually start with 50ā100 mg daily for 1ā2 weeks, then reduce to 25ā50 mg for another 2ā4 weeks. Nevertheless, bloodwork provides the most accurate guide for correct dosing.
ā ļø Possible Side Effects
- Mood swings, irritability, or mild depression.
- Visual disturbances (rare but reported).
- Headaches and digestive discomfort.
- If abused: hormonal imbalance or incomplete recovery may occur.
š Scientific References
ā Frequently Asked Questions (FAQ)
What is clomiphene citrate used for in men?
Athletes and patients use it mainly during PCT to restart testosterone production after anabolic steroid cycles.
š Source: PubMed
How does Clomid 50 work?
Clomid blocks estrogen receptors in the hypothalamus. This action signals the pituitary to release more LH and FSH, which activate the testes.
š Source: Wikipedia
Is clomiphene citrate safe for men?
Men can use it safely when doctors monitor treatment. However, misuse or long-term intake increases the risk of side effects.
š Source: DocCheck Flexikon
Reviews
There are no reviews yet.